Shares of MAXIMUS, Inc. (NYSE:MMS) have received an average recommendation of “Hold” from the nine research firms that are currently covering the company. One research analyst has rated the stock with a sell recommendation, four have given a hold recommendation and four have assigned a buy recommendation to the company. The average 12-month price target among analysts that have issued a report on the stock in the last year is $59.75.
Several brokerages have recently weighed in on MMS. Canaccord Genuity reissued a “buy” rating and issued a $62.00 target price on shares of MAXIMUS in a research note on Friday, April 7th. Jefferies Group LLC reissued a “buy” rating and issued a $64.00 target price (down previously from $65.00) on shares of MAXIMUS in a research note on Thursday, February 16th. Zacks Investment Research cut shares of MAXIMUS from a “hold” rating to a “sell” rating in a report on Friday, February 10th. Finally, Avondale Partners restated a “market perform” rating and issued a $58.00 price target on shares of MAXIMUS in a report on Tuesday, January 17th.
MAXIMUS (NYSE:MMS) traded up 0.63% during trading on Monday, reaching $60.47. The company had a trading volume of 261,574 shares. The company has a market capitalization of $3.92 billion, a price-to-earnings ratio of 20.16 and a beta of 1.13. MAXIMUS has a one year low of $43.69 and a one year high of $62.78. The company has a 50-day moving average price of $60.72 and a 200 day moving average price of $56.82.
MAXIMUS (NYSE:MMS) last announced its earnings results on Thursday, February 9th. The health services provider reported $0.71 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $0.63 by $0.08. MAXIMUS had a net margin of 8.08% and a return on equity of 26.42%. The business had revenue of $607.60 million for the quarter, compared to the consensus estimate of $599.98 million. During the same quarter in the prior year, the firm posted $0.40 earnings per share. The business’s revenue for the quarter was up 9.1% on a year-over-year basis. Analysts expect that MAXIMUS will post $3.00 earnings per share for the current year.
The company also recently declared a quarterly dividend, which will be paid on Wednesday, May 31st. Stockholders of record on Monday, May 15th will be issued a $0.045 dividend. This represents a $0.18 dividend on an annualized basis and a dividend yield of 0.30%. The ex-dividend date of this dividend is Thursday, May 11th. MAXIMUS’s dividend payout ratio is currently 5.98%.
ILLEGAL ACTIVITY NOTICE: This piece was first published by Community Financial News and is the property of of Community Financial News. If you are accessing this piece on another publication, it was copied illegally and reposted in violation of United States & international copyright law. The correct version of this piece can be read at https://www.com-unik.info/2017/04/21/maximus-inc-mms-receives-59-00-average-pt-from-brokerages-updated-updated.html.
In other MAXIMUS news, CEO Richard A. Montoni sold 30,000 shares of the firm’s stock in a transaction that occurred on Thursday, March 9th. The shares were sold at an average price of $60.59, for a total transaction of $1,817,700.00. Following the completion of the transaction, the chief executive officer now directly owns 614,114 shares of the company’s stock, valued at approximately $37,209,167.26. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. Also, Director Raymond B. Ruddy sold 9,500 shares of the firm’s stock in a transaction that occurred on Thursday, March 30th. The stock was sold at an average price of $62.53, for a total transaction of $594,035.00. Following the transaction, the director now directly owns 286,052 shares of the company’s stock, valued at $17,886,831.56. The disclosure for this sale can be found here. Insiders sold a total of 58,120 shares of company stock worth $3,547,133 over the last 90 days. Company insiders own 3.10% of the company’s stock.
Several institutional investors have recently bought and sold shares of the stock. Oregon Public Employees Retirement Fund raised its position in MAXIMUS by 2.0% in the third quarter. Oregon Public Employees Retirement Fund now owns 22,418 shares of the health services provider’s stock valued at $1,268,000 after buying an additional 447 shares during the period. Eagle Asset Management Inc. raised its position in MAXIMUS by 8.9% in the third quarter. Eagle Asset Management Inc. now owns 277,660 shares of the health services provider’s stock valued at $15,704,000 after buying an additional 22,646 shares during the period. Parametrica Management Ltd raised its position in MAXIMUS by 79.6% in the third quarter. Parametrica Management Ltd now owns 7,016 shares of the health services provider’s stock valued at $397,000 after buying an additional 3,109 shares during the period. Summit Creek Advisors LLC raised its position in MAXIMUS by 8.1% in the third quarter. Summit Creek Advisors LLC now owns 416,624 shares of the health services provider’s stock valued at $23,564,000 after buying an additional 31,150 shares during the period. Finally, Moody Aldrich Partners LLC raised its position in MAXIMUS by 10.5% in the third quarter. Moody Aldrich Partners LLC now owns 49,220 shares of the health services provider’s stock valued at $2,784,000 after buying an additional 4,670 shares during the period. 98.74% of the stock is owned by hedge funds and other institutional investors.
MAXIMUS Company Profile
MAXIMUS, Inc provides business process services (BPS) to government health and human services agencies. The Company operates through three segments: U.S. Federal Services, Health Services and Human Services. The U.S. Federal Services segment provides BPS and program management for large government programs, independent health review and appeals services for both the United States Federal Government, and state-based programs and technology solutions for civilian federal programs.
What are top analysts saying about MAXIMUS Inc.? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for MAXIMUS Inc. and related companies.